Back to Search Start Over

(J)ALEX the great: a new era in the world of ALK inhibitors

Authors :
Solenn Brosseau
Valérie Gounant
Gérard Zalcman
Source :
Journal of Thoracic Disease. 10:S2138-S2143
Publication Year :
2018
Publisher :
AME Publishing Company, 2018.

Abstract

Anaplastic lymphoma kinase ( ALK ) gene rearrangement defines a recently identified molecular subtype of non-small cell lung cancer (NSCLC), which accounts for 4–5% of all non-squamous NSCLC (1).

Details

ISSN :
20776624 and 20721439
Volume :
10
Database :
OpenAIRE
Journal :
Journal of Thoracic Disease
Accession number :
edsair.doi...........896ef20bbee7442a178047e73729f6de